All
  • All
  • Articles
  • Squawks
  • Trade views
  • Must reads
  • Videos
  • Calendar
Views
Write a Squawk
No posts
  • 27m
    fxtime fxtime
    Free Cash Flow is the crux issue as you say.
  • Squawk / 47 minutes ago
    Hypothesis Testing
    United Kingdom
    Update on prior short trade posted yesterday. As this is NFP Day....I suggest covering the trade and take profits for safety.
    Read the Squawk
  • Squawk / 1 hour ago
    Senior Equity Trader / Saxo Bank
    Denmark
    Material sector in UK are trading down by almost 1%. Worst performer among the big names are Angle Amerian (-1,45%) Rio Tinto (-1,15%) and BHP Billiton (-0,5%)
    Read the Squawk
  • Squawk / 1 hour ago
    Senior Equity Trader / Saxo Bank
    Denmark
    European stocks are trading sideways ahead of NFP later today. The number might be delay du to bad weather in Washington D.C
    Read the Squawk
  • Article / 2 hours ago

    FX Update: Can the USD bull please stand up?

    Head of FX Strategy / Saxo Bank
    Denmark
    FX Update: Can the USD bull please stand up?
    EURUSD melting lower toward 1.10 has been grabbing all of the headlines, but most of that has been a weak euro story. The USD, meanwhile, is merely among the strongest currencies rather than a true stand-out. Cue today’s US employment report for whether the USD bull is ready to charge again.
    Read the article
  • Article / 2 hours ago

    Saxo Trade Navigator: Friday, March 6

    Head of Macro Strategy / Saxo Bank
    Denmark
    Saxo Trade Navigator: Friday, March 6
    March 6, 2015: The Saxo Trade Navigator provides you with daily technical insight into almost 200 instruments, ranging from FX to equities, commodities and bonds. With a host of various technical indicators such as pivot points, RSI and moving averages, the Saxo Trade Navigator can be used to spot daily trade ideas.
    Read the article
  • Saxo TV / 3 hours ago

    Berger: NASDAQ biotechnology sector overextended

    Serge Berger
    Serge Berger, better known as The Steady Trader, is looking to short the NASDAQ Biotechnology ETF. A recent rally over the past month has extended the index well beyond its 50 and 200 day moving averages. Serge notes that biotechnology stocks are fairly volatile and it is important not to get caught on the wrong side of a pullback.
    watch video